Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myotrophin is a small (12–13 kDa), ankyrin repeat-containing protein encoded by the MTPN gene that plays a significant role in the initiation and progression of cardiac muscle hypertrophy[1][2][3][4][5]. It promotes the growth of cardiomyocytes (not proliferation), likely through interaction with the F-actin capping protein complex, inhibiting its function, and allowing actin filament extension[2][3][4]. Myotrophin also regulates the NF-kappa-B pathway by promoting dimerization of its subunits, impacting a range of cellular stress and survival pathways[3][4]. Alternative translation from the same gene produces leucine zipper protein 6, linked to myeloproliferative disease, but this is distinct from the canonical myotrophin function[3]. Myotrophin has been most intensively studied as a candidate cardiac hypertrophy protein and is being explored for its roles as a disease biomarker and a potential pharmacological target in heart failure and related conditions[1][3][5][7].
Promotes growth of cardiomyocytes via modulation of actin filament capping; Modulates NF-kappa-B activity by facilitating dimerization of its subunits
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myotrophin (MTPN).